Follow-The-Filings

Security · featured owners

PFE Pfizer Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 13 Owners
  • #64
  • Max 3.0%
  • Master 0.02%
  • $357M
  • 1 new 6 add 6 reduce 1 exit

PFE (Pfizer Inc.) is held in 13 featured 13F books as of 2026 Q2. Hillman Capital Management is the largest tracked holder by portfolio weight (3.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.0% (Hillman Capital Management) · not free-float ownership

  1. Hillman Capital Management reduce 3.0%
  2. Harry Burn add 2.8%
  3. Torray Investment Partners add 2.8%
  4. Kahn Brothers Group reduce 1.8%
  5. Prem Watsa add 0.95%
  6. Kentucky Trust Co. reduce 0.76%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Richard Pzena - Pzena Investment Management 2026 Q2 0.42% Add +0.6% 5,958,922 $143M history
Harry Burn - Sound Shore Management 2026 Q2 2.8% Add +33.1% 3,820,117 $92M history
Sarah Ketterer - Causeway Capital Management 2026 Q2 0.50% Add +0.1% 1,916,801 $46M history
Prem Watsa - Fairfax Financial Holdings 2026 Q2 0.95% Add +5.3% 1,043,900 $25M history
Torray Investment Partners 2026 Q2 2.8% Add +10.7% 859,418 $21M history
Kahn Brothers Group 2026 Q2 1.8% Reduce −4.3% 464,001 $11M history
Bruce Berkowitz - Fairholme Capital Management 2026 Q2 0.37% New 0.37% 231,000 $6M history
Hillman Capital Management 2026 Q2 3.0% Reduce −7.1% 174,610 $4M history
Dodge & Cox 2026 Q2 <0.01% Reduce −0.8% 87,814 $2M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.02% Add +1.0% 69,662 $2M history
Mairs & Power 2026 Q2 0.01% Reduce −5.8% 67,679 $2M history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 0.76% Reduce −2.4% 65,411 $2M history
Murphy Pohlad - Murphy Pohlad Asset Management 2026 Q2 0.44% Reduce −9.6% 52,377 $1M history
Senator Investment Group exited 2026 Q2 last 2026 Q1 1.6% Exit −1.61% 1,250,000 $35M history

13 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 7 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 7.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Aug 31, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Aug 5, 2026 · 2 forms Filing Doc
4 Period Jul 31, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 9, 2026 Filing Doc
4 Period Jun 30, 2026 Filing Doc
4 Period Jun 26, 2026 · 6 forms Filing Doc
4 Period Jun 15, 2026 Filing Doc
4 Period Jun 9, 2026 Filing Doc
4 Period May 29, 2026 Filing Doc
4 Period May 15, 2026 Filing Doc
4 Period Apr 30, 2026 Filing Doc
4 Period Apr 23, 2026 · 4 forms Filing Doc

Updated 13 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $50.91B — —
Gross profit * $25.96B — —
Gross margin * 51.0% — —
Net income $2.12B $8.03B $7.77B
Net margin * 4.2% — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $43.33B $50.36B $42.9B
Total non-current assets * $183.17B $163.04B $165.26B
Total assets $226.5B $213.4B $208.16B
Total current liabilities $47.79B $43B $36.98B
Total non-current liabilities * $89.42B $81.9B $84.4B
Total equity $89.01B $88.2B $86.48B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.7B $12.74B $11.7B
Cash from investing -$32.28B $2.65B -$1.35B
Cash from financing $26.07B -$17.14B -$10.3B
Net change in cash $2.45B -$1.81B $0.091B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders